Jean Zhao

Jean Zhao

Company: Crimson Bio

Job title: Founder


Targeting EGFR in in glioblastoma with a novel brain-penetrant small molecule EGFR-TKI 12:10 pm

A novel EGFR-TKi with extraordinary brain-selective distribution ( >20-fold brain to plasma ratio) It has a favorable oral PK and safety profile with a low systemic toxicity Superior activity against GBM in preclinical models (patient-derived and GEM models)Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.